The Lancet Infectious Diseases: Non-hospitalised COVID-19 patients have low-risk of serious long-term effects, but report more visits to general practitioner following infection
2021-05-11
(Press-News.org) A new study published in The Lancet Infectious Diseases journal has found that the risk of delayed acute complications after non-hospitalised SARS-CoV-2 infection is low, but persistent symptoms in this group could lead to increased visits to general practitioners or outpatient clinics in the six months following infection. The study assessed only those complications that led to contact with hospitals.
Researchers assessed the risk of initiating medication and receiving a hospital diagnosis for a new condition by comparing individuals who tested positive via a PCR test for SARS-CoV-2 with individuals who had a negative test during the first wave of the pandemic in Denmark. Results found SARS-CoV-2 positive individuals were at a slightly increased risk of initiating medications to help improve breathing and alleviate migraines, and had a slightly increased risk of receiving a first diagnosis for breathing problems and blood clots in the veins.
Senior author, Professor Anton Pottegård from the University of Southern Denmark says: "Until now, most research investigating long-term complications from COVID-19 has been focused on hospitalised patients. But the reality is that the majority of people with COVID-19 are not admitted to the hospital. Our study finds a very low risk of severe delayed effects from COVID-19 in people who didn't require hospitalisation for the infection. However, our research provided evidence for some long-term effects that did not require hospitalisation or the use of new medicines, which we found reflected in higher use of primary health-care services after infection. This highlights the need to ensure clinicians have the resources and support to manage any potential long-term conditions." [1]
The researchers used data from the Danish health registries on all individuals who were tested for SARS-CoV-2 between Feb 27, 2020, and May 31, 2020. The study followed up 8,983 non-hospitalised SARS-CoV-2 positive people and 80,894 SARS-CoV-2-negative people during the period from two weeks to six months after the test. By comparing data from the two groups, researchers assessed the relative risk of starting new medications and of receiving a diagnosis of a new health condition during this time.
The analysis took into account variables that could be associated with having a positive versus negative test and with the risk of a more severe course of COVID-19, such as obesity, cancer, and kidney disease.
The cohorts had a median age of 43 years and 64% were female. Among SARS-CoV-2 positive individuals, 31% had initiated new medication treatments during the follow up period. A more detailed analysis found that compared with those with a negative SARS-CoV-2 test those with a positive test were at an increased risk of initiating medications to widen the airways (1.8% compared with 1.5%), and medications to treat migraines (0.4% compared with 0.3%). As such, observed differences were generally small.
The risks of receiving a hospital diagnosis for a new health condition during follow up were similar in the two groups (around 26%). Compared with individuals who tested negative, those with a positive SARS-CoV-2 test were at an increased risk of receiving a first diagnosis of breathing difficulties (1.2% compared with 0.7%) and blood clots in the veins (0.2 % compared with 0.1%). No increased risk of serious complications identified by previous research conducted among individuals hospitalised for COVID-19, such as stroke, encephalitis, and psychosis, was identified among individuals who did not require hospitalisation.
The research also analysed the use of health services in the follow-up period and found that those with a positive SARS-CoV-2 test visited their general practitioners around 20% (1.2 times) more often than those that tested negative, and visited outpatient clinics 10% (1.1 times) more often. However, there was no difference in the visits to emergency department or being hospitalised.
The follow-up of the study was limited to six months after the positive test, which means the data may not have captured the longer-term complications and symptoms of COVID-19 that could occur after this time. In addition, due to the limited resources during the pandemic, some individuals with complications may have been referred to hospitals but not actually attended clinics before the end of the follow-up. This may have affected the numbers of hospital diagnoses recorded.
Commenting on the limitations of the study, co-author Stine Hasling Mogensen, PhD, from the Danish Medicines Agency adds: "Our analysis only captures specific symptoms leading to contact with hospitals, so it is likely that the study underestimates symptoms which do not require this level of care, like fatigue and breathing difficulties which are not severe enough for hospitalisation or require initiation of new medical treatment. Previous research has found a high level of these symptoms reported by patients, so the differences between patient reports and healthcare encounters could be important to investigate in regards to potential unmet healthcare needs and the need for new medications for treatment." [1]
The researchers call for large population-based studies of patient-reported symptoms and healthcare visits to fully evaluate the duration and range of any persisting symptoms after SARS-CoV-2 infection.
INFORMATION:
Peer-reviewed / Observational Study / People
NOTES TO EDITORS
This study received no funding. It was conducted by researchers from University of Southern Denmark, Aalborg University, Statens Serum Institut, University of Copenhagen, Danish Medicines Agency and Aarhus University Hospital.
[1] Quote direct from author and cannot be found in the text of the Article.
The labels have been added to this press release as part of a project run by the Academy of Medical Sciences seeking to improve the communication of evidence. For more information, please see: http://www.sciencemediacentre.org/wp-content/uploads/2018/01/AMS-press-release-labelling-system-GUIDANCE.pdf if you have any questions or feedback, please contact The Lancet press office pressoffice@lancet.com
IF YOU WISH TO PROVIDE A LINK FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00211-5/fulltext
ELSE PRESS RELEASES FROM THIS DATE:
2021-05-11
Antibiotic resistance in E. coli has been steadily increasing since the early 2000s despite attempts to control it, a new study suggests. In the biggest genomic survey of E. coli to date, that took more than 16 years in Norway, researchers have successfully tracked the spread of antibiotic resistant genes and have shown that these genes are being transferred between E. coli strains.
Researchers from the Wellcome Sanger Institute and University of Oslo have tracked multidrug resistance in Norway and compared this to a previous study from the UK. They found that ...
2021-05-11
As more private data is stored and shared digitally, researchers are exploring new ways to protect data against attacks from bad actors. Current silicon technology exploits microscopic differences between computing components to create secure keys, but artificial intelligence (AI) techniques can be used to predict these keys and gain access to data. Now, Penn State researchers have designed a way to make the encrypted keys harder to crack.
Led by Saptarshi Das, assistant professor of engineering science and mechanics, the researchers used graphene -- a layer of carbon one atom thick -- to develop a novel low-power, scalable, reconfigurable hardware security device with significant resilience ...
2021-05-10
According to the International Whaling Commission, whale-watching tourism generates more than $2.5 billion a year. After the COVID-19 pandemic, this relatively safe outdoor activity is expected to rebound. Two new studies funded by a collaborative initiative between the Smithsonian Tropical Research Institute (STRI) in Panama and Arizona State University (ASU) show how science can contribute to whale watching practices that ensure the conservation and safety of whales and dolphins.
"The Smithsonian's role is to provide scientific advice to policy makers as they pioneer management strategies to promote whale conservation," said STRI marine biologist, Hector Guzmán, whose previous work led the International Maritime Organization to establish ...
2021-05-10
Conducting a discussion in a noisy place can be challenging when other conversations and background noises interfere with our ability to focus attention on our conversation partner. How the brain deals with the abundance of sounds in our environments, and prioritizes among them, has been a topic of debate among cognitive neuroscientists for many decades.
Often referred to as the "Cocktail Party Problem", its central question focuses on whether we can absorb information from a few speakers in parallel, or whether we are limited to understanding speech from only one speaker at a time.
One ...
2021-05-10
Chemotherapy can induce a painful peripheral neuropathy (CIPN), a chronic condition and common adverse effect for cancer patients undergoing treatment. Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, have used a mouse model to demonstrate the pivotal role of cholesterol in CIPN, and proposed a novel therapeutic approach to reverse it.
The findings are published in the May 10, 2021, online issue of the Journal of Experimental Medicine.
The study was a collaboration between the laboratories of senior study author Yury Miller, MD, PhD, professor of medicine, and Tony Yaksh, PhD, professor of anesthesiology and pharmacology, both at UC San Diego School of Medicine. ...
2021-05-10
Evidence of recent volcanic activity on Mars shows that eruptions could have taken place in the past 50,000 years, according to new study by researchers at the University of Arizona's Lunar and Planetary Laboratory and the Planetary Science Institute.
Most volcanism on the Red Planet occurred between 3 and 4 billion years ago, with smaller eruptions in isolated locations continuing perhaps as recently as 3 million years ago. But, until now, there was no evidence to indicate Mars could still be volcanically active.
Using data from satellites orbiting Mars, researchers discovered a previously unknown volcanic ...
2021-05-10
All three species of manatee now present on Earth share a common ancestor from which they split some 6.5 million years ago, when a huge lake in Amazonia, then linked to the Caribbean, was cut off from the sea. The African manatee Trichechus senegalensis is not as genetically close to the West Indian manatee T. manatus as was thought, and adaptation to this complex environment by the Amazonian manatee T. inunguis has left at least one mark in its genetic code.
These are key findings of a study supported by FAPESP and published in Scientific Reports, with hitherto unknown details of the evolutionary history of these aquatic mammals. The authors are an international group of scientists led by researchers at the University of Campinas ...
2021-05-10
The American College of Chest Physicians® (CHEST) recently released new clinical guidelines on the Diagnosis and Evaluation of Hypersensitivity Pneumonitis (HP). The guidelines contain 14 evidence-based recommendations to improve individual diagnostic decision-making and to decrease diagnostic practice variability.
Occurring at any age, HP is an immunologically mediated form of lung disease resulting from inhalational exposure to a large variety of environmental and/or occupational inciting antigens (typically fungal, bacterial, avian). Over the years, the categorization of HP based on clinical features and disease duration coupled with traditional diagnostic criteria has been unhelpful, even when accurate, when separated from a probabilistic diagnostic ...
2021-05-10
Clavelina oblonga, an invasive marine fouling species, not only reduces diversity in communities it invades, it also interferes in their recovery following natural disasters - a process known as "succession."
Succession refers to how an ecosystem recovers after a disturbance or natural disaster - does the system come back more or less the same as it was in terms of species composition, or is it different?
"The classic example of succession is a forest that experiences a wildfire," says Kayla Christianson, former NC State graduate student and first author of a paper describing the research. "As the community recovers from the fire, it proceeds through a predictable pattern of community development - starting with grasses and ending with trees and a mature forest. This ...
2021-05-10
Since it debuted in 2011, the Get SET Early program, which provides pediatricians and parents with a relatively simple process to screen for indicators of autism spectrum disorder (ASD) in children as young as age 1, has steadily grown in use and validation. Early screening and identification of ASD has been linked to more effective treatment.
A new study, published in the April 26, 2021 issue of the END ...
LAST 30 PRESS RELEASES:
[Press-News.org] The Lancet Infectious Diseases: Non-hospitalised COVID-19 patients have low-risk of serious long-term effects, but report more visits to general practitioner following infection
